Scientific Session
Fibrosing rheumatic diseases (scleroderma, MCTD, IgG4-related disease, scleroderma mimics)
Michael Whitfield, PhD
Geisel School of Medicine
Lebanon, NH, United States
Disclosure(s): Boehringer-Ingelheim: Advisor or Review Panel Member (Ongoing); Bristol-Myers Squibb(BMS): Consultant (Ongoing), Grant/Research Support (Ongoing); Celdara Medical: Consultant (Ongoing), Grant/Research Support (Ongoing), Scientific Founder (Ongoing)